1. Home
  2. WOR vs SLNO Comparison

WOR vs SLNO Comparison

Compare WOR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worthington Enterprises Inc.

WOR

Worthington Enterprises Inc.

HOLD

Current Price

$47.08

Market Cap

2.8B

ML Signal

HOLD

Logo Soleno Therapeutics Inc.

SLNO

Soleno Therapeutics Inc.

HOLD

Current Price

$34.16

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WOR
SLNO
Founded
1955
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Aerospace
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.3B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
WOR
SLNO
Price
$47.08
$34.16
Analyst Decision
Buy
Strong Buy
Analyst Count
3
11
Target Price
$59.67
$108.00
AVG Volume (30 Days)
108.5K
1.3M
Earning Date
03-16-2026
05-29-2026
Dividend Yield
1.62%
N/A
EPS Growth
N/A
108.90
EPS
1.25
0.39
Revenue
$1,153,762,000.00
$1,450,788.00
Revenue This Year
$18.05
$155.44
Revenue Next Year
$5.29
$57.99
P/E Ratio
$37.56
$94.31
Revenue Growth
N/A
138.82
52 Week Low
$39.05
$32.63
52 Week High
$70.91
$89.12

Technical Indicators

Market Signals
Indicator
WOR
SLNO
Relative Strength Index (RSI) 21.52 32.76
Support Level N/A $32.63
Resistance Level $56.72 $44.60
Average True Range (ATR) 1.53 2.45
MACD -0.99 -0.18
Stochastic Oscillator 8.75 14.19

Price Performance

Historical Comparison
WOR
SLNO

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products and services, including manufactured metal products. The company operates under two reportable operating segments: Consumer Products and Building Products. The consumer Products business has a diverse product offering in the tools, outdoor living and celebrations categories, including propane-filled cylinders for torches, handheld torches, specialized hand tools, drywall tools, accessories and gas grills, and others. And the Building Products business engaged in providing pressurized containment solutions, providing critical components in the residential, non-residential, and repair and remodel end markets through essential categories. The company derives majority of the revenue from Building Products segment.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: